Cargando…
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Parkinson’s disease is a chronic neurodegenerative disease characterized by the accumulation of misfolded alpha-synuclein protein (Lewy bodies) in dopaminergic neurons of the substantia nigra and other related circuitry, which contribute to the development of both motor (bradykinesia, tremors, stiff...
Autores principales: | Klann, Emily M., Dissanayake, Upuli, Gurrala, Anjela, Farrer, Matthew, Shukla, Aparna Wagle, Ramirez-Zamora, Adolfo, Mai, Volker, Vedam-Mai, Vinata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776990/ https://www.ncbi.nlm.nih.gov/pubmed/35069178 http://dx.doi.org/10.3389/fnagi.2021.782082 |
Ejemplares similares
-
Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
por: Hey, Grace, et al.
Publicado: (2023) -
The “Brittle Response” to Parkinson’s Disease Medications: Characterization and Response to Deep Brain Stimulation
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2014) -
Evaluation of an Adoptive Cellular Therapy-Based Vaccine
in a Transgenic Mouse Model of α-synucleinopathy
por: Chu, Winston T., et al.
Publicado: (2022) -
Bacteriophages Reduce Pathogenic Escherichia coli Counts in Mice Without Distorting Gut Microbiota
por: Dissanayake, Upuli, et al.
Publicado: (2019) -
STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s Disease
por: Wong, Joshua K., et al.
Publicado: (2020)